Connecticut 2011 Regular Session

Connecticut Senate Bill SB00183

Introduced
1/18/11  
Introduced
1/18/11  
Refer
1/18/11  
Refer
1/18/11  
Refer
3/3/11  
Refer
3/3/11  
Report Pass
4/26/11  
Report Pass
4/26/11  
Refer
4/29/11  
Refer
4/29/11  
Report Pass
5/5/11  

Caption

An Act Creating A Childhood Immunization Task Force.

Impact

The establishment of this task force is anticipated to lead to significant improvements in the management of childhood immunizations in the state. By coordinating efforts among key players in public health and ensuring an effective response to evolving vaccine recommendations, the task force could enhance the state's ability to maintain high vaccination rates. This is particularly important in light of emerging diseases and changes in national healthcare policies affecting child immunization practices.

Summary

SB00183, titled 'An Act Creating A Childhood Immunization Task Force', establishes a task force dedicated to enhancing childhood immunization within the state. The bill mandates the task force to develop strategies for maintaining access to vaccines, addressing new immunization recommendations from the CDC, and managing the costs associated with childhood immunizations. Comprised of various stakeholders, including representatives from the pharmaceutical and insurance industries, as well as public health officials, the task force aims to provide a structured response to the state's immunization needs.

Sentiment

The sentiment regarding SB00183 is generally positive among public health advocates and stakeholders, who recognize the importance of maintaining high immunization rates among children. Proponents argue that the task force will help streamline vaccine administration and ensure that children receive necessary immunizations in a timely manner. However, some concerns have been raised regarding the bureaucratic nature of the task force and whether it will be able to effectively address the rapidly changing landscape of immunizations.

Contention

Notable points of contention include the balance of interests represented on the task force, particularly regarding the weight given to pharmaceutical and insurance industry representatives versus public health perspectives. Critics argue that the presence of these industry representatives might influence decisions in ways that prioritize profit over public health needs. Furthermore, there are questions about the long-term impacts of the task force's recommendations, particularly in terms of funding and resource allocation for immunization programs.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.